$DOCU

Marrs Anna sold $20K of DOCU

Marrs Anna sold 365 shares of DOCUSIGN, INC. (DOCU) at $55.04 on 2026-06-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Marrs Anna
Published Jun 2, 2026, 10:46 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 2, 2026, 10:47 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$DOCU
Neutral
medium confidence
Mentioned
$DOCU
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$DOCUNeutralLow
01

Why it matters

The disclosure adds a fresh datapoint on insider activity but does not indicate a new fundamental development for DOCUSIGN.

02

Market read

Traders may factor the insider sale into short-term sentiment, but the 10b5-1 structure reduces the likelihood of a meaningful fundamental repricing.

03

What to watch

Consider whether there are other recent insider buys/sells or larger transactions around the same window; a single small sale often has limited interpretive power.

Relevance 6/10Novelty 7/10Timing: Filed today (2026-06-02) after-hours SEC Form 4 disclosure

Background

The article is an SEC Form 4 insider transaction disclosure for a DOCUSIGN director, including trade size, price, and confirmation of a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$DOCUNeutralMedium confidence
Context

DOCUSIGN disclosed a director open-market sale of 365 shares at $55.04 via an SEC Form 4 filed today under a 10b5-1 plan.

Expected impact

Likely limited/short-lived impact; any move would be more sentiment-driven than fundamental.

Evidence & confidence

The filing is a routine, pre-arranged director sale (10b5-1), with no accompanying operational or financial catalyst in the article.

Market effects

Minimal; this is company-specific insider activity with no sector-wide regulatory/product signal.

None.

None.

Counterpoint

Because it’s a 10b5-1 plan, the sale may reflect scheduled liquidity needs rather than bearish expectations—market reaction could be overdone.

Key entities

  • DOCUSIGN, Inc.

    Subject of the SEC Form 4 insider sale disclosure (director open-market sale under 10b5-1).

  • Marrs Anna

    Director who sold 365 shares at $55.0400/share; holdings after transaction: 12,615 shares.

Related articles

$LULUMed

Stock Market Today: Dow Futures Gain, S&P 500 Slips As Trump Floats Meeting Iran's Supreme Leader— Lulule

U.S. stock futures were mixed Friday: Nasdaq 100 and S&P 500 slipped while Dow futures rose after a mixed prior close. President Trump said he would consider meeting Iran’s Supreme Leader Ayatollah Mojtaba Khamenei if diplomacy progresses. Treasury yields were 4.46% (10-year) and 4.03% (2-year); FedWatch priced a 96.4% chance of no June rate change. Lululemon, Docusign (-4.73%), Samsara (-5.14%), and Keel (-8.94% on $350m convertibles) were among movers.

$LULUHighAI 9/10

Stocks making the biggest moves after hours: Lululemon Athletica, ServiceTitan, Argan and more

After-hours movers: Lululemon shares fell 10% after it cut full-year earnings and revenue guidance and its current-quarter outlook missed analyst expectations, per LSEG. Docusign slipped 4% as its Q2 revenue outlook ($865M–$869M) met but didn’t beat estimates. Guidewire dropped 16% on weaker adjusted gross margin. ServiceTitan rose 12% after raising full-year guidance.

$DOCUMedAI 9/10

DocuSign Delivers Beat-And-Raise Q1, But Investors Aren't Impressed - Docusign (NASDAQ:DOCU)

DocuSign reported Q1 revenue of $830.2 million, slightly above the $824.77 million consensus, and adjusted EPS of $1.09 versus $0.99 expected, according to Benzinga Pro. Revenue rose 9% YoY; free cash flow was $289.4 million. The company repurchased $317.5 million of stock and raised FY revenue guidance to $3.49–$3.502 billion. Shares were down 4.02% after hours to $48.85.

$DOCUMedAI 9/10

DocuSign (DOCU) Q1 Earnings Report Preview: What To Look For

DocuSign will report Q1 results Thursday after the bell, according to the article. The company’s prior quarter revenue was $836.9 million (+7.8% YoY), but it missed annual recurring revenue estimates. For Q1, analysts expect revenue +8.1% YoY. The article cites an average analyst price target of $59.88 vs. $55.18.